<DOC>
	<DOC>NCT01543880</DOC>
	<brief_summary>This study is conducted in Europe. The aim of the study is to evaluate safety and efficacy in adults treated with somatropin (NorditropinÂ®).</brief_summary>
	<brief_title>Safety and Efficacy of Long-term Somatropin Treatment in Adults</brief_title>
	<detailed_description />
	<mesh_term>Dwarfism, Pituitary</mesh_term>
	<criteria>In need of somatropin or current user</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>